Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Our client is a global Employer of Record (EOR) company. An Employer of Record is a third-party organisation that serves as the legal employer of a worker on behalf of a client company. The EOR takes
About Our Client Our client is a global Employer of Record (EOR) company. An Employer of Record is a third-party organisation that serves as the legal employer of a worker on behalf of a client company.